The early stages of any new, clinically impactful drug put pressure on benefit leaders. While research evolves at a pace that keeps health care professionals on their toes, benefit leaders must make precise decisions that have a big impact on the people they cover and their organization.to use GLP-1s for chronic weight management, and they’re understandably concerned about the coverage costs for a drug with this level of demand.
When something causes discontinuation, it’s the provider’s role to help patients safely navigate through medication changes and set expectations. Benefit leaders may inadvertently contribute to this challenge by supporting vendors who claim successful “deprescribing” in large populations. So, what strategies can be used to address cost-driven pressures for GLP-1s? At Teladoc Health, we recognize five clinically appropriate options.
to extend the time between medication. The effectiveness of this approach is still being evaluated but is something Teladoc Health is keeping a close eye on.